天賜材料(002709.SZ):終止境外發行全球存託憑證事項
格隆匯4月14日丨天賜材料(002709.SZ)公佈,2025年4月11日,廣州天賜高新材料股份有限公司召開第六屆董事會第三十一次會議及第六屆監事會第二十四次會議,審議通過了《關於終止境外發行全球存託憑證事項的議案》,同意公司終止境外發行全球存託憑證(Global Depository Receipts,以下簡稱“GDR”)並在瑞士證券交易所(SIXSwiss Exchange)掛牌上市的計劃。
鑑於內外部環境等因素髮生變化,公司結合實際情況,並與相關中介機構經過深入探討和謹慎分析後,決定終止本次境外發行GDR事項。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.